Cervical cancer
Spatially Fractionated Radiation Treatment for Gynaecological Cancers
Who can joinWomen
Age18–70 years
Kind of studyStudy of how care is given
What it testsRadiation
The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.
Where to go
1 hospital in India taking patients for this trial.
ACTREC Tata Memorial CentreNavi Mumbai, MaharashtraDirections ↗
Registry summary (technical)
This is a prospective study to evaluate in-field disease control, survival and late toxicity in patients with cervical cancer or pelvic recurrence treated with spatially fractionated RT. The study will include patients with primary cervical cancer or pelvic recurrence not suitable for brachytherapy in view of anticipated or actual suboptimal target coverage due to aberrant anatomy or large residual disease at the time of brachytherapy.
Sponsor: Tata Memorial Hospital
NCT06644846 on ClinicalTrials.gov
Last updated on the registry 20 Feb 2026 · read by us 20 Oct 2026